Stem Cell    Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis J Am Coll Cardiol (2008) 51; 1429-37 D. Zohlnhofer, A. Dibra, T. Koppara, A. de Waha, R. S. Ripa, J. Kastrup, M. Valgimigli, A. Schomig and A. Kastrati Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function Heart (2008) 94; 1147-53 K. Yao, R. Huang, J. Qian, J. Cui, L. Ge, Y. Li, F. Zhang, H. Shi, D. Huang, S. Zhang, A. Sun, Y. Zou and J. Ge Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction J Am Coll Cardiol (2009) 53; 1-9 W. Wojakowski, M. Tendera, M. Kucia, E. Zuba-Surma, E. Paczkowska, J. Ciosek, M. Halasa, M. Krol, M. Kazmierski, P. Buszman, A. Ochala, J. Ratajczak, B. Machalinski and M. Z. Ratajczak Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial Eur Heart J (2009) M. Tendera, W. Wojakowski, W. Ruzyllo, L. Chojnowska, C. Kepka, W. Tracz, P. Musialek, W. Piwowarska, J. Nessler, P. Buszman, S. Grajek, P. Breborowicz, M. Majka and M. Z. Ratajczak Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction Am Heart J (2008) 155; 55 e1-9 S. Solheim, I. Seljeflot, K. Lunde, P. Aukrust, A. Yndestad, H. K. Grogaard, S. Aakhus, K. Forfang and H. Arnesen Autologous cell-based therapy for ischemic heart disease: clinical evidence, proposed mechanisms of action, and current limitations Catheter Cardiovasc Interv (2009) 73; 281-8 E. C. Perin and G. V. Silva Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review Eur Heart J (2008) 29; 1807-18 E. Martin-Rendon, S. J. Brunskill, C. J. Hyde, S. J. Stanworth, A. Mathur and S. M. Watt Stem cell therapy is proarrhythmic Circulation (2009) 119; 1814-23 E. Macia and P. A. Boyden Stem cells are not proarrhythmic: letting the genie out of the bottle Circulation (2009) 119; 1824-31 H. Q. Ly and S. Nattel Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up J Am Coll Cardiol (2008) 51; 674-6 K. Lunde, S. Solheim, K. Forfang, H. Arnesen, L. Brinch, R. Bjornerheim, A. Ragnarsson, T. Egeland, K. Endresen, A. Ilebekk, A. Mangschau and S. Aakhus Cell therapy in acute myocardial infarction: measures of efficacy Heart (2008) 94; 969-70 K. Lunde and S. Aakhus Imaging survival and function of transplanted cardiac resident stem cells J Am Coll Cardiol (2009) 53; 1229-40 Z. Li, A. Lee, M. Huang, H. Chun, J. Chung, P. Chu, G. Hoyt, P. Yang, J. Rosenberg, R. C. Robbins and J. C. Wu Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction. First-in-man study Heart (2009) K. Krause, K. Jaquet, C. Schneider, M. Lioznov, K. M. Otte, S. Haupt and K. H. Kuck Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction Eur Heart J (2008) 29; 2851-8 M. Korf-Klingebiel, T. Kempf, T. Sauer, E. Brinkmann, P. Fischer, G. P. Meyer, A. Ganser, H. Drexler and K. C. Wollert Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis Heart (2008) 94; 610-6 H. Ince, M. Valgimigli, M. Petzsch, J. S. de Lezo, F. Kuethe, S. Dunkelmann, G. Biondi-Zoccai and C. A. Nienaber Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction Eur Heart J (2008) 29; 2723-32 H. V. Huikuri, K. Kervinen, M. Niemela, K. Ylitalo, M. Saily, P. Koistinen, E. R. Savolainen, H. Ukkonen, M. Pietila, J. K. Airaksinen, J. Knuuti and T. H. Makikallio Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study Eur Heart J (2009) 30; 662-70 L. Herbots, J. D'Hooge, E. Eroglu, D. Thijs, J. Ganame, P. Claus, C. Dubois, K. Theunissen, J. Bogaert, J. Dens, M. Kalantzi, S. Dymarkowski, B. Bijnens, A. Belmans, M. Boogaerts, G. Sutherland, F. Van de Werf, F. Rademakers and S. Janssens Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy Am Heart J (2009) 157; 541-7 T. Dill, V. Schachinger, A. Rolf, S. Mollmann, H. Thiele, H. Tillmanns, B. Assmus, S. Dimmeler, A. M. Zeiher and C. Hamm Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism Circulation (2008) 117; 1610-9 P. Deedwania, M. Kosiborod, E. Barrett, A. Ceriello, W. Isley, T. Mazzone and P. Raskin Release of biomarkers of myocardial damage after direct intramyocardial injection of genes and stem cells via the percutaneous transluminal route Eur Heart J (2008) 29; 1819-26 F. Baldazzi, E. Jorgensen, R. S. Ripa and J. Kastrup